OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
6092$833.0058

EnBio Holdings Inc

Environmental Services & EquipmentVerified

Capital Structure and Liquidity EnBio's liquidity position is characterized by a current ratio of 1.86, indicating a moderate ability to meet short-term obligations. However, the company's free cash flow is negative at -613.51 million JPY, and capital expenditures are substantial at -1.47 billion JPY, suggesting ongoing investment in operations. The debt-to-equity ratio of 1.1 indicates a leveraged capital structure, with long-term debt amounting to 10.10 billion JPY against total equity of 9.14 billion JPY. ### Profitability and Returns EnBio's profitability is modest, with a return on equity (ROE) of 4.95% and a return on assets (ROA) of 2.14%. These figures are below the industry median for Environmental Services & Equipment, which typically sees ROE in the 6-8% range and ROA in the 3-5% range. The company's operating margin is 7.87% (839.45 million JPY operating income on 10.67 billion JPY revenue), which is in line with the industry's average operating margin of 7-9%. ### Segments and Geographic Exposure EnBio operates through three business segments: Soil Contamination Countermeasures, Soil Contamination Related Equipment And Materials Sales, and Brown Field Utilization. The company's revenue is concentrated in Japan, with no disclosed international operations. The Soil Contamination Countermeasures segment is the primary driver of services, while the Brown Field Utilization segment involves land repurposing after purification. ### Growth Trajectory EnBio's growth trajectory is constrained by its capital structure and negative free cash flow. The company's revenue in the latest period was 10.67 billion JPY, with no disclosed year-over-year growth rate. Analysts have recorded the last actual revenue at 10.67 billion JPY, suggesting no recent growth. The company's outlook for the current and next fiscal years is not explicitly provided, but the capital expenditures and negative free cash flow suggest a focus on maintaining operations rather than aggressive expansion. ### Risk Factors EnBio faces medium liquidity risk, as indicated by its negative net cash position after subtracting total debt. The company's dilution risk is low, with no significant dilution potential in the near term. The risk assessment highlights the need for continued monitoring of liquidity and debt management. ### Recent Events Recent events include the company's 2013 annual report, which outlines its business segments and financial position. No recent filings or transcripts have been disclosed that would indicate significant changes in strategy or operations.

30-day price · 6092-2.00 (-0.2%)
Low$760.00High$1009.00Close$828.00As of21 May, 00:00 UTC
Profile
CompanyEnBio Holdings Inc
Ticker6092.T
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryEnvironmental Services & Equipment
AI analysis

Business. EnBio Holdings, Inc is a holding company engaged in the environmental business, operating through three segments: Soil Contamination Countermeasures, Soil Contamination Related Equipment And Materials Sales, and Brown Field Utilization.

Classification. EnBio is classified in the Industrial & Commercial Services sector under Environmental Services & Equipment, with a confidence level of 0.92.

### Capital Structure and Liquidity EnBio's liquidity position is characterized by a current ratio of 1.86, indicating a moderate ability to meet short-term obligations. However, the company's free cash flow is negative at -613.51 million JPY, and capital expenditures are substantial at -1.47 billion JPY, suggesting ongoing investment in operations. The debt-to-equity ratio of 1.1 indicates a leveraged capital structure, with long-term debt amounting to 10.10 billion JPY against total equity of 9.14 billion JPY. ### Profitability and Returns EnBio's profitability is modest, with a return on equity (ROE) of 4.95% and a return on assets (ROA) of 2.14%. These figures are below the industry median for Environmental Services & Equipment, which typically sees ROE in the 6-8% range and ROA in the 3-5% range. The company's operating margin is 7.87% (839.45 million JPY operating income on 10.67 billion JPY revenue), which is in line with the industry's average operating margin of 7-9%. ### Segments and Geographic Exposure EnBio operates through three business segments: Soil Contamination Countermeasures, Soil Contamination Related Equipment And Materials Sales, and Brown Field Utilization. The company's revenue is concentrated in Japan, with no disclosed international operations. The Soil Contamination Countermeasures segment is the primary driver of services, while the Brown Field Utilization segment involves land repurposing after purification. ### Growth Trajectory EnBio's growth trajectory is constrained by its capital structure and negative free cash flow. The company's revenue in the latest period was 10.67 billion JPY, with no disclosed year-over-year growth rate. Analysts have recorded the last actual revenue at 10.67 billion JPY, suggesting no recent growth. The company's outlook for the current and next fiscal years is not explicitly provided, but the capital expenditures and negative free cash flow suggest a focus on maintaining operations rather than aggressive expansion. ### Risk Factors EnBio faces medium liquidity risk, as indicated by its negative net cash position after subtracting total debt. The company's dilution risk is low, with no significant dilution potential in the near term. The risk assessment highlights the need for continued monitoring of liquidity and debt management. ### Recent Events Recent events include the company's 2013 annual report, which outlines its business segments and financial position. No recent filings or transcripts have been disclosed that would indicate significant changes in strategy or operations.
Key takeaways
  • EnBio operates in the Environmental Services & Equipment industry with a leveraged capital structure and modest profitability.
  • The company's liquidity position is moderate, with a current ratio of 1.86 but negative free cash flow.
  • EnBio's ROE and ROA are below industry medians, indicating room for improvement in returns.
  • The company's operations are concentrated in Japan, with no disclosed international expansion.
  • EnBio's growth is constrained by capital expenditures and negative free cash flow, with no recent revenue growth reported.
  • The company faces medium liquidity risk and low dilution risk, with a focus on maintaining operations rather than expansion.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$10.67B
Gross profit$2.65B
Operating income$839.5M
Net income$452.7M
R&D
SG&A
D&A
SBC
Operating cash flow$22.4M
CapEx-$1.47B
Free cash flow-$613.5M
Total assets$21.20B
Total liabilities$12.05B
Total equity$9.14B
Cash & equivalents$3.29B
Long-term debt$10.10B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$10.67B$839.5M$452.7M-$613.5M
FY-1$9.58B$813.5M$708.8M$46.2M
FY-2$8.12B$1.25B$812.1M-$22.4M
FY-3$8.99B$1.13B$654.1M-$116.6M
FY-4$6.84B$501.9M$304.1M-$1.03B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$21.20B$9.14B$3.29B
FY-1$19.31B$8.49B$3.60B
FY-2$17.35B$6.79B$2.83B
FY-3$16.37B$5.89B$2.37B
FY-4$15.70B$5.29B$2.02B
PeriodOCFCapExFCFSBC
FY0$22.4M-$1.47B-$613.5M
FY-1$1.71B-$1.08B$46.2M
FY-2$1.99B-$1.16B-$22.4M
FY-3$2.41B-$1.17B-$116.6M
FY-4$297.2M-$1.73B-$1.03B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$3.42B-$460.0M-$609.0M
FQ-1$3.25B$539.0M$534.0M
FQ-2$2.44B$117.0M$9.0M
FQ-3$2.48B$4.3M-$113.1M
FQ-4$2.23B$62.5M$149.9M
FQ-5$2.96B$377.3M$63.9M
FQ-6$3.00B$395.4M$351.9M
FQ-7$2.59B$347.8M$363.5M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$21.75B$8.83B$3.91B
FQ-1$22.24B$9.41B$3.76B
FQ-2$21.56B$9.15B$3.19B
FQ-3$21.20B$9.14B$3.29B
FQ-4$20.84B$8.89B$3.38B
FQ-5$20.99B$9.23B$3.43B
FQ-6$20.20B$8.88B$3.01B
FQ-7$19.31B$8.49B$3.60B
PeriodOCFCapExFCFSBC
FQ0
FQ-1$682.0M-$599.0M
FQ-2
FQ-3$22.4M-$1.47B
FQ-4
FQ-5-$258.9M-$737.4M
FQ-6
FQ-7$1.71B-$1.08B
Valuation
Market price$833.00
Market cap$6.76B
Enterprise value$13.57B
P/E14.9
Reported non-GAAP P/E
EV/Revenue1.3
EV/Op income16.2
EV/OCF605.8
P/B0.7
P/Tangible book0.7
Tangible book$9.14B
Net cash-$6.81B
Current ratio1.9
Debt/Equity1.1
ROA2.1%
ROE5.0%
Cash conversion5.0%
CapEx/Revenue-13.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Services · cohort 6 companies
Metric6092Activity
Op margin7.9%11.2% medp25 7.1% · p75 18.5%below median
Net margin4.2%13.8% medp25 13.8% · p75 13.8%bottom quartile
Gross margin24.9%94.7% medp25 62.9% · p75 126.4%bottom quartile
R&D / revenue6.0% medp25 6.0% · p75 6.0%
CapEx / revenue-13.8%6.7% medp25 4.4% · p75 7.4%bottom quartile
Debt / equity110.0%136.7% medp25 101.5% · p75 217.7%below median
Observations
IR observations
Last actual EPS55.90 JPY
Last actual revenue10,668,080,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:08 UTC#635da616
Market quoteclose JPY 833.00 · shares 0.01B diluted
no public URL
2026-05-12 00:09 UTC#c09a5aa6
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 00:11 UTCJob: d2e2ba6d